WNK2 and neoplasm: Previous studies hypothesized that tumor resistance to MAPK/ERK (mitogen-activated protein kinase/extracellular signal-regulated kinase) inhibition may be the result of a negative feedback loop formed by the activation of AKT in response to ERK inhibition (27–29).